Goldman Sachs analyst Rajan Sharma maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) yesterday and set a price target of ...

Bank of America Securities analyst Graham Parry has maintained their bearish stance on GSK stock, giving a Sell rating on December 11.Pick the ...

A design team including Haworth Tompkins, Metropolitan Workshop, dRMM and Studio Egret West is drawing up a major ...

We welcome the decision by the UK Joint Committee on Vaccination and Immunisation (JCVI) to broaden the eligibility for the vaccination programme for the Shingrix recombinant herpes zoster vaccine ...

Physicians, nurse practitioners, or physician assistants prescribed medication to patients with OUD, while intervention ...

Key players in the market include pharmaceutical companies such as GlaxoSmithKline, Pfizer, Sanofi, Johnson & Johnson and ...

A study from University of Michigan researchers may explain why some patients with Crohn’s disease continue to experience symptoms, even in the absence of inflammation.

The incidence and prevalence of genital HSV type 1 and 2 infections are high worldwide, contributing to the burden of genital ulcer disease.

GlaxoSmithKline ( ($GB:GSK) ) has provided an announcement. GSK announced that its B7-H3-targeted antibody-drug conjugate, GSK’227, has received ...

incorporated in the year 1924, is a Large Cap company (having a market cap of Rs 39,514.80 Crore) operating in Pharmaceuticals sector. GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue ...

An update from GlaxoSmithKline ( ($GB:GSK) ) is now available. GSK announced that its drug Jemperli (dostarlimab) has received the US FDA ...

News for GlaxoSmithKline Consumer Healthcare Ltd. Google.org Grants $1 Million to Karya for AI Upskilling in India Google.org awards USD 1 million to Karya, an Indian non-profit, to empower low-income ...